Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortIL-6 receptor antibody for rheumatoid arthritis, giant cell arteritis and cytokine storm.Biologic injection for arthritis, IBD and psoriasis.
Body systemJoints & ImmunityJoints & Immunity
Drug classInterleukin inhibitorsTNF inhibitors
SupplyPrescription onlyWHO essential medicinePrescription only
Main usesRheumatoid arthritis, Giant cell arteritis, Systemic juvenile arthritis, Cytokine release syndrome, Severe COVID-19 (selected patients)Rheumatoid and psoriatic arthritis, Ankylosing spondylitis, Crohn's disease and ulcerative colitis, Psoriasis, Hidradenitis suppurativa
How it worksBlocks an inflammation signal called IL-6.Mops up a key inflammation signal.
Starts workingWeeks—
Half-lifeDose-dependent, up to about 2 weeksAbout 2 weeks
Typical adult dose162 mg subcutaneously weekly or every two weeks; or 8 mg/kg IV every 4 weeks.40 mg under the skin every other week (some conditions start higher or go weekly).
FormsSubcutaneous injection, IV infusionPre-filled pen, Pre-filled syringe
Common side effectsUpper respiratory infections, Headache, Raised liver enzymes, Raised cholesterol, Injection site reactionsInjection-site reactions, Upper respiratory infections, Headache
Serious side effectsSerious infections including TB, Bowel perforation, Low blood counts, Liver injurySerious infections including TB reactivation, Lymphoma (rare), Demyelination, Heart failure worsening
Don't take ifActive serious infection; Active TB—
AlcoholBest to limit. Alcohol adds to liver strain.—
PregnancyUse with cautionLimited data; avoid unless needed.Use with cautionOften continued into pregnancy for IBD; baby's live vaccines may be delayed.
BreastfeedingUse with cautionLimited data.—
In use since—2002
Brand namesUnited States: Actemra, TofidenceUnited Kingdom: RoActemraIndia: Actemra, Tocilizumab biosimilars (Bmab etc.)United States: Humira, Hadlima, Hyrimoz, YuflymaUnited Kingdom: Humira, Amgevita, Imraldi, YuflymaIndia: Exemptia, Adfrar
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H—
ATC codeL04AC07L04AB04

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker